Nevro Corp (NVRO)
5.29
+0.09
(+1.73%)
USD |
NYSE |
Sep 27, 16:00
5.285
0.00 (0.00%)
After-Hours: 20:00
Nevro Cash from Financing (TTM): 43.20M for June 30, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 43.20M |
March 31, 2024 | 45.33M |
December 31, 2023 | 49.53M |
September 30, 2023 | 2.21M |
June 30, 2023 | 3.26M |
March 31, 2023 | 2.023M |
December 31, 2022 | -2.457M |
September 30, 2022 | -0.555M |
June 30, 2022 | -1.917M |
March 31, 2022 | -174.66M |
December 31, 2021 | -169.38M |
September 30, 2021 | -167.52M |
June 30, 2021 | -165.43M |
March 31, 2021 | 329.26M |
December 31, 2020 | 346.90M |
September 30, 2020 | 363.16M |
June 30, 2020 | 365.40M |
March 31, 2020 | 46.50M |
December 31, 2019 | 32.09M |
September 30, 2019 | 12.00M |
Date | Value |
---|---|
June 30, 2019 | 9.405M |
March 31, 2019 | 7.802M |
December 31, 2018 | 7.754M |
September 30, 2018 | 9.049M |
June 30, 2018 | 11.73M |
March 31, 2018 | 10.82M |
December 31, 2017 | 11.20M |
September 30, 2017 | 13.68M |
June 30, 2017 | 11.46M |
March 31, 2017 | 146.64M |
December 31, 2016 | 145.16M |
September 30, 2016 | 142.33M |
June 30, 2016 | 142.04M |
March 31, 2016 | 123.38M |
December 31, 2015 | 122.83M |
September 30, 2015 | 272.96M |
June 30, 2015 | 271.55M |
March 31, 2015 | 152.13M |
December 31, 2014 | 152.08M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-174.66M
Minimum
Mar 2022
365.40M
Maximum
Jun 2020
47.95M
Average
7.632M
Median
Cash from Financing (TTM) Benchmarks
Myomo Inc | 9.312M |
Inspire Medical Systems Inc | 1.24M |
Axonics Inc | 1.945M |
Inari Medical Inc | -0.681M |
Electromed Inc | 0.036M |